Page 3 - Robert Ajer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 182,787 shares of the biotechnology company’s stock after buying an additional 1,866 shares during […]

BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) was upgraded by stock analysts at Sanford C. Bernstein from an “underperform” rating to a “market perform” rating in a report released on Monday, Briefing.com reports. The brokerage presently has a $82.00 target price on the biotechnology company’s stock. Sanford C. Bernstein’s target price indicates a potential downside […]

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 6,570,000 shares, a growth of 5.1% from the August 31st total of 6,250,000 shares. Based on an average daily trading volume, of 1,290,000 […]

Raymond James started coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) in a report issued on Thursday, MarketBeat.com reports. The firm issued a market perform rating on the biotechnology company’s stock. A number of other analysts have also weighed in on the stock. 500.com reiterated a reiterates rating on shares of BioMarin Pharmaceutical […]

Cannon Global Investment Management LLC acquired a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,000 shares of the biotechnology company’s stock, valued at approximately $433,000. BioMarin Pharmaceutical […]